A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Clinical trial NCT05481151 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05481151
- Sponsor
- PharmaEssentia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2025-06-30
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.